Dublin, Sept. 14, 2021 (GLOBE NEWSWIRE) -- The "Extracorporeal Membrane Oxygenation Machine Market Research Report by Modality, by Age, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Extracorporeal Membrane Oxygenation Machine Market size was estimated at USD 292.52 Million in 2020 and expected to reach USD 317.67 Million in 2021, at a Compound Annual Growth Rate (CAGR) 8.93% to reach USD 488.82 Million by 2026.
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Extracorporeal Membrane Oxygenation Machine to forecast the revenues and analyze the trends in each of the following sub-markets:
- Based on Modality, the Extracorporeal Membrane Oxygenation Machine Market was studied across Arteriovenous ECMO, Venoarterial ECMO, and Venovenous ECMO.
- Based on Application, the Extracorporeal Membrane Oxygenation Machine Market was studied across Cardiac Application, Extracorporeal Cardiopulmonary Resuscitation, and Respiratory Application.
- Based on Age, the Extracorporeal Membrane Oxygenation Machine Market was studied across Adult, Neonate, and Pediatric.
- Based on Region, the Extracorporeal Membrane Oxygenation Machine Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Extracorporeal Membrane Oxygenation Machine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Extracorporeal Membrane Oxygenation Machine Market, including Abbott Laboratories, Alung Technologies, Inc., Eurosets S.R.L., Getinge AB, Livanova PLC, Medtronic PLC, Microport Scientific Corporation, Nipro Corporation, Origen Biomedical, Inc., Terumo Corporation, and Xenios AG.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Extracorporeal Membrane Oxygenation Machine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Extracorporeal Membrane Oxygenation Machine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Extracorporeal Membrane Oxygenation Machine Market?
4. What is the competitive strategic window for opportunities in the Global Extracorporeal Membrane Oxygenation Machine Market?
5. What are the technology trends and regulatory frameworks in the Global Extracorporeal Membrane Oxygenation Machine Market?
6. What is the market share of the leading vendors in the Global Extracorporeal Membrane Oxygenation Machine Market?
7. What modes and strategic moves are considered suitable for entering the Global Extracorporeal Membrane Oxygenation Machine Market?
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of cardiovascular and respiratory diseases
5.1.1.2. Increased adoption of ECMO systems owing to technology advancement
5.1.2. Restraints
5.1.2.1. Dearth of skilled professionals
5.1.3. Opportunities
5.1.3.1. Adoption of ECMO in the settings of lung transplantation and technical advancements
5.1.3.2. Rising awareness about the benefits of ECMO machines
5.1.4. Challenges
5.1.4.1. High cost associated with the ECMO procedures
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. Extracorporeal Membrane Oxygenation Machine Market, by Modality
6.1. Introduction
6.2. Arteriovenous ECMO
6.3. Venoarterial ECMO
6.4. Venovenous ECMO
7. Extracorporeal Membrane Oxygenation Machine Market, by Application
7.1. Introduction
7.2. Cardiac Application
7.3. Extracorporeal Cardiopulmonary Resuscitation
7.4. Respiratory Application
8. Extracorporeal Membrane Oxygenation Machine Market, by Age
8.1. Introduction
8.2. Adult
8.3. Neonate
8.4. Pediatric
9. Americas Extracorporeal Membrane Oxygenation Machine Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Extracorporeal Membrane Oxygenation Machine Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand
11. Europe, Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. Alung Technologies, Inc.
13.3. Eurosets S.R.L.
13.4. Getinge AB
13.5. Livanova PLC
13.6. Medtronic PLC
13.7. Microport Scientific Corporation
13.8. Nipro Corporation
13.9. Origen Biomedical, Inc.
13.10. Terumo Corporation
13.11. Xenios AG
14. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/o6iy9d
